J. Stéphenne

发表

Production of poliovirus vaccines: past, present, and future.

M. Duchêne, J. Peetermans, E. D'hondt, 1990, Viral immunology.

Safety and immunogenicity of an inactivated hepatitis A candidate vaccine in healthy adult volunteers.

C. Kunz, J. Stéphenne, A. Safary, 1990, Vaccine.

The New Global Economics of Vaccines: Will the Scientific Potential Be Realised?

J. Stéphenne, 2007 .

Development and production aspects of a recombinant yeast-derived hepatitis B vaccine.

J. Stéphenne, 1990, Vaccine.

Recombinant versus plasma-derived hepatitis B vaccines: issues of safety, immunogenicity and cost-effectiveness.

J. Stéphenne, 1988, Vaccine.

Selective pro-apoptotic and antimigratory effects of polyphenol complex catechin:lysine 1:2 in breast, pancreatic and colorectal cancer cell lines.

J. Stéphenne, P. Sonveaux, F. Martel, 2019, European journal of pharmacology.

Immunological properties of recombinant HBsAg produced in yeast.

E. Simoen, J. Stéphenne, H. Thomas, 1987, Postgraduate medical journal.

The need for new vaccines.

J. Stéphenne, K. Taylor, Aurélia Nguyen, 2009, Vaccine.

Contribution to hepatitis B prevention.

J. Stéphenne, 1992, Vaccine.

Vaccine varicella-zoster virus

E. Hanon, J. Stéphenne, 2006 .

Production in yeast versus mammalian cells of the first recombinant DNA human vaccine and its proved safety, efficacy, and economy: hepatitis B vaccine.

J. Stéphenne, 1990, Advances in biotechnological processes.

The need for new vaccines.

J. Stéphenne, K. Taylor, Aurélia Nguyen, 2009, Vaccine.